B Cell News and Research

RSS

Scientists move one step closer to a HIV cure

Scientists found no rebound of HIV in two patients who stopped taking their HIV medication after they received stem cell transplants for a hematological [blood] disease. Both patients underwent stem cell transplantation as part of their cancer treatment.

6 Mar 2019

Discovery of protein, lipid connection could lead to new influenza therapies

The connection between an influenza virus surface protein and a host cell lipid has been discovered by researchers at the University of Maine and the National Institutes of Health. Confirmation of direct interaction between the protein and lipid could lead to new antiviral therapies.

6 Mar 2019

New mathematical method to map cell regulatory networks

Faster results. Lower costs. Fewer cells. A new mathematical method developed by researchers at Cincinnati Children's and New York University may soon make it much easier to conduct more of the complex data analysis needed to drive advances in the exploding field of personalized medicine.

6 Mar 2019

Low-calorie 'fasting-mimicking' diet has potential to treat people with IBD

What if a special diet could reduce inflammation and repair your gut? USC researchers provided evidence that a low-calorie "fasting-mimicking" diet has the potential to do just that.

6 Mar 2019

Liver tissue model can help investigate the effects of RNA interference

Novel therapies based on a process known as RNA interference hold great promise for treating a variety of diseases by blocking specific genes in a patient's cells. Many of the earliest RNAi treatments have focused on diseases of the liver, because RNA-carrying particles tend to accumulate in that organ.

6 Mar 2019

New approach to creating 'theranostics' for targeting specific tumors, diseases

A City of Hope scientist and his colleagues have developed a user-friendly approach to creating "theranostics" - therapy combined with diagnostics - that target specific tumors and diseases.

6 Mar 2019

Second man cured of HIV

A London is now free of HIV/AIDS after a stem cell transplant therapy. This is the second such case after the first case of cured HIV in Berlin.

5 Mar 2019

New insights into influenza A infection and its spread

A new route of influenza A infection viruses has been discovered by the researchers at the Medical Center - University of Freiburg and the University of Zurich. At present the knowledge regarding influenza A infection spread is mainly restricted to the binding of the sialic moieties of the virus to the cell surface of the host.

5 Mar 2019

New therapeutic approach for patients with pancreatic cancer

One-year survival is low among patients diagnosed with pancreatic cancer. Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have now come up with a potential new therapy for pancreatic cancer patients.

5 Mar 2019

Study sheds new light on early development of embryos

By applying gene analysis to individual cells from early mouse embryos, researchers at Karolinska Institutet in Sweden have discovered previously unknown cellular stages of fetal development from fertilized egg to living being. The study is published in the scientific journal Cell Reports.

5 Mar 2019

British man with HIV becomes second person ever to enter remission

A man in Britain has become the second person in the world to be cleared of HIV after receiving a stem cell transplant from an HIV-resistant donor.

5 Mar 2019

Colon cancer could be made more aggressive by common oral bacteria

Scientists have identified a common oral bacterium that accelerates colon cancer growth. The discovery could pave the way for new treatments.

5 Mar 2019

Lonza expands portfolio with addition of new 'Verified for Spheroids Human Hepatocytes'

Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture.

From Lonza 5 Mar 2019

Oxford Genetics successfully negotiates six licensing deals

Mercia Technologies PLC, the national investment group focused on the identification, creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, today announces that its portfolio company, Oxford Genetics Limited, has successfully negotiated six licensing deals for its scalable gene therapy manufacturing technologies in the last twelve months.

From OXGENE 5 Mar 2019

Bacteria-killing glass offers hope to combat deadliest hospital infections

Scientists at Aston University have discovered a technique similar to medieval stained glass-making that can completely eradicate the deadliest hospital infections within hours.

5 Mar 2019

Isolating Bacterial Pathogen DNA from Food Samples

Isolating bacterial pathogen DNA is important and often seen as QA ensure that the food manufactured or the ingredients used do not contain food-borne bacteria.

From Promega Corporation 5 Mar 2019

Study unravels microscopic mysteries in the brains of C. elegans

It's the small pieces that make the big picture, and in this case, the pieces can't be seen by the naked eye. New research at the Okinawa Institute of Science and Technology Graduate Universit used microscopy techniques to piece together the brain of the millimeter-long Caenorhabditis elegans, revealing that their neurons fire action potentials - a spike in voltage due to neurons sending sensory information in the cell membrane.

5 Mar 2019

Researchers identify common genetic signature among three rare skin diseases

A group of researchers lead by a lecturer from the Universidad Carlos III de Madrid, Marcela del Río, from the CIEMAT, the Rare Diseases Networking Biomedical Research Centre and Fundación Jiménez Díaz has identified a common genetic signature among three rare skin diseases or genodermatoses: recessive dystrophic epidermolysis bullosa, Kindler syndrome and xeroderma pigmentosum.

5 Mar 2019